Eligibility NCT00329303 Psoriasis

Eligibility

Subject having responded to treatment in study C87040 and having relapsed during the follow-up period.

Ja

Nein

Ausschlusskriterien

Erythrodermic, guttate, palmar or plantar, generalized pustular form of psoriasis

Ja

Nein

A history of chronic infection, recent serious or life-threatening infection (within six months, including herpes zoster), or any current sign or symptom that may indicate an infection (e.g. fever, cough)

Ja

Nein

Leukozyten-Anzahl

Ja

Nein

Suspected or diagnosed demyelinating disease of the central nervous system (e.g. multiple sclerosis or optic neuritis)

Ja

Nein

systemischer Lupus erythematodes

Ja

Nein

Non respect of adequate wash out periods for treatments that might have an impact on the disease

Ja

Nein

Any associated disease that could be impacted by the study treatment intake

Ja

Nein

Any other condition, which in the Investigator's judgment would make the subject unsuitable for inclusion in the study